BDTX

Black Diamond Therapeutics Stock Analysis

AI Rating

Great
  • Quality5/10
  • Growth↑ 8/10
  • Value↑ 8/10
Black Diamond Therapeutics sales and earnings growth
BDTX Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 130.71%
  • FCF Y/Y↑ 147.65%
Black Diamond Therapeutics gross and profit margin trends
BDTX Profitability
Great
  • Gross margin ↑ 100.00%
  • EPS margin↑ 32.00%
  • ROIC 5Y↑ -42.17%
Black Diamond Therapeutics net debt vs free cash flow
BDTX Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Black Diamond Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗